Literature DB >> 2671181

A brief guide to the practice of radioimmunoscintigraphy and radioimmunotherapy in cancer. Report of the European Association of Nuclear Medicine Task Group on the clinical utility of labelled antibodies.

K E Britton1, G L Buraggi, R Bares, A Bischof-Delaloye, U Buell, D Emrich, M Granowska.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2671181     DOI: 10.1177/172460088900400208

Source DB:  PubMed          Journal:  Int J Biol Markers        ISSN: 0393-6155            Impact factor:   3.248


× No keyword cloud information.
  4 in total

Review 1.  Antibody-guided scintigraphy: targeting of the "magic bullet".

Authors:  F Fazio; G Paganelli
Journal:  Eur J Nucl Med       Date:  1993-12

2.  European multicentre study on melanoma immunoscintigraphy by means of 99mTc-labelled monoclonal antibody fragments. The European Multicentre Study Group.

Authors:  A G Siccardi; G L Buraggi; P G Natali; G A Scassellati; G Viale; S Ferrone
Journal:  Eur J Nucl Med       Date:  1990

3.  Radioimmunoscintigraphy with technetium-99m labelled monoclonal antibody, 1A3, in colorectal cancer.

Authors:  M Granowska; K E Britton; S J Mather; G Morris; D Ellison; S Soobramoney; I C Talbot; J M Northover
Journal:  Eur J Nucl Med       Date:  1993-08

4.  Complete ablation of small squamous cell carcinoma xenografts with 186Re-labeled monoclonal antibody E48.

Authors:  M Gerretsen; G W Visser; R H Brakenhoff; M van Walsum; G B Snow; G A van Dongen
Journal:  Cell Biophys       Date:  1994
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.